<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2d1 20170631//EN" "JATS-journalpublishing1.dtd">
<article xlink="http://www.w3.org/1999/xlink" dtd-version="1.0" article-type="healthcare" lang="en"><front><journal-meta><journal-id journal-id-type="publisher">IJCRR</journal-id><journal-id journal-id-type="nlm-ta">I Journ Cur Res Re</journal-id><journal-title-group><journal-title>International Journal of Current Research and Review</journal-title><abbrev-journal-title abbrev-type="pubmed">I Journ Cur Res Re</abbrev-journal-title></journal-title-group><issn pub-type="ppub">2231-2196</issn><issn pub-type="opub">0975-5241</issn><publisher><publisher-name>Radiance Research Academy</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1094</article-id><article-id pub-id-type="doi"/><article-id pub-id-type="doi-url"/><article-categories><subj-group subj-group-type="heading"><subject>Healthcare</subject></subj-group></article-categories><title-group><article-title>STUDY OF LIPID PEROXIDATION PRODUCT, SULPHYDRYL PROTEINS (-SH) AND ANTIOXIDANT STATUS IN SMOKERS&#13;
</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Raut</surname><given-names>Anita M.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Suryakar</surname><given-names>A.N.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Mhaisekar</surname><given-names>Dilip</given-names></name></contrib></contrib-group><pub-date pub-type="ppub"><day>25</day><month>09</month><year>2013</year></pub-date><volume>)</volume><issue/><fpage>15</fpage><lpage>21</lpage><permissions><copyright-statement>This article is copyright of Popeye Publishing, 2009</copyright-statement><copyright-year>2009</copyright-year><license license-type="open-access" href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made.</license-p></license></permissions><abstract><p>Lipid peroxide plays an important role in smokers. Increased epithelial permeability produced by cigarette smoke is likely to be mediated through depletion of sulphydryl proteins (-SH) and antioxidant capacity. The oxidant burden in the lungs is enhanced in smokers by the release of ROS from macrophages and neutrophils. Oxidants present in cigarette smoke can stimulate alveolar macrophages to produce ROS some of which attack neutrophils and other inflammatory cells into lungs. 60 smokers with smoking history 20 pkts /year were included in the study.100 healthy non-smokers__ampersandsignrsquo; were served as controls. Their base line clinical examination, malondialdehyde (MDA), sulphydryl proteins (-SH), superoxide dismutase (SOD) and total antioxidant capacity (TAC) were measured. The mean malondialdehyde levels in the patients at base line were high (P__ampersandsignlt; 0.001) than Controls. The sulphydryl proteins, superoxide dismutase and total antioxidant capacity were low (P__ampersandsignlt;0.001) in the smokers compared to controls. We found decreased levels of sulphydryl proteins and increased levels of lipid peroxide (MDA) in smokers. Thus the present study confirmed the existence of oxidative stress and alteration in enzymatic and nonenzymatic antioxidant (-SH Proteins) status.&#13;
</p></abstract><kwd-group><kwd>Sulphydryl proteins</kwd><kwd> Malondialdehyde</kwd><kwd> Antioxidant status</kwd><kwd> Superoxide Dismutase</kwd><kwd> Smokers’</kwd><kwd> Reactive Oxygen Species (ROS).</kwd></kwd-group></article-meta></front></article>
